Skip to main content
Clinical Trials/NCT03209596
NCT03209596
Completed
Not Applicable

Nutritional and Biochemical Effects of Orange Juice Supplementation in Soccer Players: a Double Blind, Randomized and Controlled Trial

Ellen Cristini de Freitas1 site in 1 country30 target enrollmentStarted: October 20, 2013Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Ellen Cristini de Freitas
Enrollment
30
Locations
1
Primary Endpoint
Food intake

Overview

Brief Summary

This study aimed to verify if orange juice supplementation can be a nutritional strategy to ensure an adequate energy and micronutrients ingestion, influencing metabolic responses of soccer players.

Detailed Description

Thirty-four male soccer players aged 18.5 ± 0.5 years and BMI (Body Mass Index) of 21.41 ± 1.48 kg/cm2 were randomly divided into two parallel groups: (1) orange juice (n = 17), composed of individuals receiving 1 liter/day of orange juice; (2) control (n = 17) composed of individuals receiving 1 liter/day of control drink with the same proportion of total sugars as the orange juice. The recruitment process began in September 2013, the intervention was carried out from November 2013 to January 2014, and the data analysis started in February 2014. The sample size took into account the variances in total cholesterol, considering the high statistical variability of biochemical markers, which requires a sufficient number of samples to ensure representativeness and adequate statistical power of analysis, and that the reduction of total cholesterol is associated to the regular consumption of orange juice (Dourado et al., 2015). Based on unpublished data from a previous pilot experiment, it was expected that the total cholesterol of orange juice group would be 10% lower in relation to control group after intervention (orange juice = 123.41 ± 12.12 mg/dL, control drink = 37.80 ± 11.17 mg/dL). Thus, with a type I error α = 0.05 and a type II error β = 0.2 (80% power) the minimum sample size should have 12 individuals per group (n = 24). Considering the high layoffs rate in the team, the initial sample size of study was constituted by 17 individuals per group (n = 34). During the intervention, four individuals from control drink group failed the study protocol, and the study was concluded with 30 participants (orange juice n = 17 and control drink n = 13). Primary and secondary endpoints were the improvement of food intake and changes in biochemical markers, respectively. Shapiro Wilk and Levene tests evaluated normality and homogeneity of data, respectively. T-test was conducted to identify possible differences between groups at baseline. A mixed factorial ANOVA was applied to determine the effect of treatment and time, within and between groups (Sidak post hoc test), and statistical significance was set at p < 0.05. Food intake, biochemical biomarkers and body composition were assessed before and after the 60 days of intervention.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Masking Description

All assignments and group randomization were performed by a research team member who was not directly involved in the study. The masking of the volunteers was performed by the control drink. For statistical analysis of the results, the masking was maintained by conferring fictitious names to the groups.

Eligibility Criteria

Ages
18 Years to 19 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Three consecutive years of soccer training prior to the start of the study.

Exclusion Criteria

  • Historic of chronic disease, use of hormones, drugs, vitamins supplements and/or other dietary supplements during the study.

Outcomes

Primary Outcomes

Food intake

Time Frame: 60 days

Food intake was assessed by 24-hour recall

Secondary Outcomes

  • Glucose(60 days)
  • Glycated hemoglobin(60 days)
  • Total cholesterol(60 days)
  • Low Density Lipoprotein Cholesterol (LDL-C)(60 days)
  • High Density Lipoprotein Cholesterol (HDL-C)(60 days)
  • Triglycerides(60 days)
  • Creatinine(60 days)

Investigators

Sponsor
Ellen Cristini de Freitas
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Ellen Cristini de Freitas

PhD

University of Sao Paulo

Study Sites (1)

Loading locations...

Similar Trials